Cargando…

NAFLD - A rising metabolic disease

Detalles Bibliográficos
Autor principal:	Zeigerer, Anja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324679/ https://www.ncbi.nlm.nih.gov/pubmed/34229990 http://dx.doi.org/10.1016/j.molmet.2021.101274

Ejemplares similares

Molecular Mechanisms of NAFLD in Metabolic Syndrome
por: Martins, Maria João, et al.
Publicado: (2015)

Metabolic regulation through the endosomal system
por: Gilleron, Jerome, et al.
Publicado: (2019)

Recent Developments in NAFLD
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Metabolic syndrome in Indian children – An alarming rise
por: Ganie, M. Ashraf
Publicado: (2010)

NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Chronic Kidney Disease is on the Rise
por: Haileamlak, Abraham
Publicado: (2018)

The rise and rise of Indian Journal of Ophthalmology
por: Honavar, Santosh G
Publicado: (2022)

From NAFLD to MAFLD: a “redefining” moment for fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020)

NAFLD: Is There Anything New under the Sun?
por: Lonardo, Amedeo, et al.
Publicado: (2017)

NAFLD: From Mechanisms to Therapeutic Approaches
por: Gariani, Karim, et al.
Publicado: (2022)

Are We Ready for the Rising Silent Epidemic of Metabolic Syndrome and Chronic Non-Communicable Disease in Ethiopia?
por: Belachew, Tefera
Publicado: (2015)

Lean NAFLD: A not so benign condition?
por: VanWagner, Lisa B., et al.
Publicado: (2018)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories
por: Kantartzis, Konstantinos, et al.
Publicado: (2023)

The rise and fall and rise of benzodiazepines: a return of the stigmatized and repressed
por: Balon, Richard, et al.
Publicado: (2020)

Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2021)

Triglycerides on the Rise!
por: Tada, Hayato, et al.
Publicado: (2021)

Rising to the challenge
por: Pines, Jon
Publicado: (2021)

Rising Star
por: Wojtys, Edward M.
Publicado: (2012)

Rising in the World
Publicado: (1849)

Is the Mediterranean Diet the Best Approach to NAFLD Treatment Today?
por: Angelico, Francesco, et al.
Publicado: (2021)

Risk Factors for Colorectal Adenoma – Acknowledging the Burden of NAFLD
por: Duvnjak, Marko, et al.
Publicado: (2019)

Staging NAFLD: Diagnostic and Therapeutic Value of TAM Signaling
por: Cubero, Francisco Javier
Publicado: (2019)

The heated debate over NAFLD renaming: An ongoing saga
por: Yilmaz, Yusuf
Publicado: (2023)

Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2022)

NAFLD as a risk factor for HCC: new rules of engagement?
por: Masuzaki, Ryota, et al.
Publicado: (2016)

Fatal attraction? The rise of disease management programmes in Europe
por: Goodwin, Dr. Nick
Publicado: (2007)

Venezuela and its rising vector-borne neglected diseases
por: Hotez, Peter J., et al.
Publicado: (2017)

The Sun also rises
por: Sarinho, Emanuel, et al.
Publicado: (2021)

The rise of the digital revolution
por: Hing, Caroline, et al.
Publicado: (2021)

The rise of Bioscience in the East
por: Jeang, Kuan-Teh
Publicado: (2010)

Quantitative biology on the rise
por: Mogilner, Alex
Publicado: (2016)

Rising to the challenge of multimorbidity
por: Whitty, Christopher J M, et al.
Publicado: (2020)

The rise of novel antimicrobials
por: Maillard, Jean‐Yves, et al.
Publicado: (2022)

Metabolic Changes of Hepatocytes in NAFLD
por: Lu, Qianrang, et al.
Publicado: (2021)

Engaging a Rising China through Neglected Tropical Diseases
por: Hotez, Peter J.
Publicado: (2012)

Comorbidities and Metabolic Derangement of NAFLD
por: Bang, Ki Bae, et al.
Publicado: (2015)

The rise and rise of technology in urology– Cost-effective medicine vs. new treatments
por: Kekre, Nitin S.
Publicado: (2012)

From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2014)

Dysregulated lipid metabolism links NAFLD to cardiovascular disease
por: Deprince, Audrey, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s0bniqt9pmavaalrhh84l9177o